Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kim D. Mooiman"'
Publikováno v:
Cancer Treatment Reviews. 39:773-783
The use of complementary and alternative medicines (CAM) by cancer patients is increasing. Concomitant use of CAM and anticancer drugs could lead to serious safety issues in patients. CAM have the potential to cause pharmacokinetic interactions with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f142056fa8f3529f62c08a375c253e
https://doi.org/10.1016/j.ctrv.2012.12.008
https://doi.org/10.1016/j.ctrv.2012.12.008
Autor:
Kim D. Mooiman, Roel F. Maas-Bakker, Jos H. Beijnen, Irma Meijerman, C. Lau, Jan H.M. Schellens
Publikováno v:
Journal of Ethnopharmacology. 149:543-549
Ethnopharmacological relevance Traditional Chinese Medicine (TCM) has become more popular among cancer patients in the Western world, who often use Chinese herbs as adjuvant therapy to reduce the adverse effects of conventional chemotherapy. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b625d4beb485800233924af57404b644
https://doi.org/10.1016/j.jep.2013.07.014
https://doi.org/10.1016/j.jep.2013.07.014
Autor:
Hilde Rosing, Irma Meijerman, Kim D. Mooiman, Roel F. Maas-Bakker, Jos H. Beijnen, Jan H.M. Schellens
Publikováno v:
Biomedical Chromatography. 27:1107-1116
Complementary and alternative medicines (CAM) can affect the pharmacokinetics of anticancer drugs by interacting with the metabolizing enzyme cytochrome P450 (CYP) 3A4. To evaluate changes in the activity of CYP3A4 in patients, levels of 1-hydroxymid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::766e96829274af19ab8b0cfab03c88c6
https://doi.org/10.1002/bmc.2913
https://doi.org/10.1002/bmc.2913
Autor:
Ed E. Moret, Jos H. Beijnen, Kim D. Mooiman, Jan H.M. Schellens, Roel F. Maas-Bakker, Irma Meijerman
Publikováno v:
Drug Metabolism and Disposition. 41:1494-1504
Because cancer is often treated with combination therapy, unexpected pharmacological effects can occur because of drug-drug interactions. Several drugs are able to cause upregulation or downregulation of drug transporters or cytochrome P450 enzymes,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89e510d725918c8c6f94bf9618cc585
https://doi.org/10.1124/dmd.113.050971
https://doi.org/10.1124/dmd.113.050971
Publikováno v:
The oncologist. 17(5)
The safety, tolerability, and efficacy of the mixture of botanical compounds known as LCS101 were evaluated in the prevention of chemotherapy-induced hematological toxicity in breast cancer patients in a prospective, controlled study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e8657d301801bd32aa797fbd2a42dbe8
https://pubmed.ncbi.nlm.nih.gov/21712486
https://pubmed.ncbi.nlm.nih.gov/21712486
Publikováno v:
The Oncologist. 17:740-741
Based on the results of a prospective, randomized, placebo-controlled study of Yaal-Hahoshen et al., [1] the authors concluded that the botanical mixture LCS101 prevented hematological complications in breast cancer patients undergoing anthracycline-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef6521d8c9a6fafe989eb796795bd879
https://doi.org/10.1634/theoncologist.2011-0413
https://doi.org/10.1634/theoncologist.2011-0413
Publikováno v:
Cancer Research. 72:3791-3791
Introduction Many anticancer drugs, such as paclitaxel and erlotinib, are able to induce the expression of cytochrome P450 (CYP450) 3A4.1 Induction of intestinal and hepatic CYP3A4 can result in a decreased uptake and an increased metabolism of antic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bf865599e9832a716308a1a8675d17f
https://doi.org/10.1158/1538-7445.am2012-3791
https://doi.org/10.1158/1538-7445.am2012-3791